These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 21788507)

  • 1. Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2-mediated heparin-binding EGF signaling in endothelial cells.
    Svensson KJ; Kucharzewska P; Christianson HC; Sköld S; Löfstedt T; Johansson MC; Mörgelin M; Bengzon J; Ruf W; Belting M
    Proc Natl Acad Sci U S A; 2011 Aug; 108(32):13147-52. PubMed ID: 21788507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development.
    Kucharzewska P; Christianson HC; Welch JE; Svensson KJ; Fredlund E; Ringnér M; Mörgelin M; Bourseau-Guilmain E; Bengzon J; Belting M
    Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7312-7. PubMed ID: 23589885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of protease activated receptor 1 and 2 signaling in hypoxia-induced angiogenesis.
    Uusitalo-Jarvinen H; Kurokawa T; Mueller BM; Andrade-Gordon P; Friedlander M; Ruf W
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1456-62. PubMed ID: 17363687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor VIIa-induced interaction with integrin controls the release of tissue factor on extracellular vesicles from endothelial cells.
    Rothmeier AS; Versteeg HH; Ruf W
    J Thromb Haemost; 2019 Apr; 17(4):627-634. PubMed ID: 30740873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both Autocrine Signaling and Paracrine Signaling of HB-EGF Enhance Ocular Neovascularization.
    Inoue Y; Shimazawa M; Nakamura S; Takata S; Hashimoto Y; Izawa H; Masuda T; Tsuruma K; Sakaue T; Nakayama H; Higashiyama S; Hara H
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):174-185. PubMed ID: 29191924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A potent anti-HB-EGF monoclonal antibody inhibits cancer cell proliferation and multiple angiogenic activities of HB-EGF.
    Sato S; Drake AW; Tsuji I; Fan J
    PLoS One; 2012; 7(12):e51964. PubMed ID: 23251664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue factor-factor VIIa complex triggers protease activated receptor 2-dependent growth factor release and migration in ovarian cancer.
    Chanakira A; Westmark PR; Ong IM; Sheehan JP
    Gynecol Oncol; 2017 Apr; 145(1):167-175. PubMed ID: 28148395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human airway trypsin-like protease induces amphiregulin release through a mechanism involving protease-activated receptor-2-mediated ERK activation and TNF alpha-converting enzyme activity in airway epithelial cells.
    Chokki M; Eguchi H; Hamamura I; Mitsuhashi H; Kamimura T
    FEBS J; 2005 Dec; 272(24):6387-99. PubMed ID: 16336275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue factor in cancer progression and angiogenesis.
    Ruf W; Yokota N; Schaffner F
    Thromb Res; 2010 Apr; 125 Suppl 2(0 2):S36-8. PubMed ID: 20434002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of tissue factor/protease-activated receptor-2 signaling limits proliferation, migration and invasion of malignant glioma cells.
    Gessler F; Voss V; Dützmann S; Seifert V; Gerlach R; Kögel D
    Neuroscience; 2010 Feb; 165(4):1312-22. PubMed ID: 19958818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAR2-SMAD3 in microvascular endothelial cells is indispensable for vascular stability via tissue factor signaling.
    Arderiu G; Espinosa S; Peña E; Aledo R; Badimon L
    J Mol Cell Biol; 2016 Jun; 8(3):255-70. PubMed ID: 26658897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for tissue factor phosphorylation and its correlation with protease-activated receptor expression and the prognosis of primary breast cancer.
    Rydén L; Grabau D; Schaffner F; Jönsson PE; Ruf W; Belting M
    Int J Cancer; 2010 May; 126(10):2330-40. PubMed ID: 19795460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of tissue factor signaling suppresses tumor growth.
    Versteeg HH; Schaffner F; Kerver M; Petersen HH; Ahamed J; Felding-Habermann B; Takada Y; Mueller BM; Ruf W
    Blood; 2008 Jan; 111(1):190-9. PubMed ID: 17901245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-binding EGF-like growth factor (HB-EGF) mediates 5-HT-induced insulin resistance through activation of EGF receptor-ERK1/2-mTOR pathway.
    Li Q; Hosaka T; Shikama Y; Bando Y; Kosugi C; Kataoka N; Nakaya Y; Funaki M
    Endocrinology; 2012 Jan; 153(1):56-68. PubMed ID: 22028447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-binding epidermal growth factor-like growth factor promotes transcoelomic metastasis in ovarian cancer through epithelial-mesenchymal transition.
    Yagi H; Yotsumoto F; Miyamoto S
    Mol Cancer Ther; 2008 Oct; 7(10):3441-51. PubMed ID: 18852147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional Regulation of Thrombin-Induced Endothelial VEGF Induction and Proangiogenic Response.
    Catar R; Moll G; Hosp I; Simon M; Luecht C; Zhao H; Wu D; Chen L; Kamhieh-Milz J; Korybalska K; Zickler D; Witowski J
    Cells; 2021 Apr; 10(4):. PubMed ID: 33920990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular hierarchy of heparin-binding EGF-like growth factor-regulated angiogenesis in triple-negative breast cancer.
    Yotsumoto F; Tokunaga E; Oki E; Maehara Y; Yamada H; Nakajima K; Nam SO; Miyata K; Koyanagi M; Doi K; Shirasawa S; Kuroki M; Miyamoto S
    Mol Cancer Res; 2013 May; 11(5):506-17. PubMed ID: 23443317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis.
    Mehta VB; Zhou Y; Radulescu A; Besner GE
    Growth Factors; 2008 Dec; 26(6):301-15. PubMed ID: 18925469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential pathways of angiotensin II-induced extracellularly regulated kinase 1/2 phosphorylation in specific cell types: role of heparin-binding epidermal growth factor.
    Shah BH; Yesilkaya A; Olivares-Reyes JA; Chen HD; Hunyady L; Catt KJ
    Mol Endocrinol; 2004 Aug; 18(8):2035-48. PubMed ID: 15143154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HB-EGF promotes angiogenesis in endothelial cells via PI3-kinase and MAPK signaling pathways.
    Mehta VB; Besner GE
    Growth Factors; 2007 Aug; 25(4):253-63. PubMed ID: 18092233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.